Analyze the information and social media posts to determine if the closing price of $amgn will ascend or descend at 2017-06-29. Please respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-15,0.1,0.5,-1.0,-0.6,-0.6,0.2,-0.9,-2.4,-3.2,-3.2,-2.9
2017-06-16,0.9,1.0,-0.8,-1.0,-1.0,1.1,0.3,-1.1,-2.0,-2.1,-1.9
2017-06-19,-1.2,0.1,-1.5,1.6,1.6,-0.5,-1.0,-2.3,-3.4,-3.5,-3.4
2017-06-20,-0.5,1.4,-0.9,0.7,0.7,-1.0,-1.3,-2.5,-3.7,-4.1,-4.0
2017-06-21,-2.4,0.2,-2.9,3.0,3.0,-3.2,-3.7,-4.8,-6.0,-6.6,-6.7
2017-06-22,-0.8,0.9,-1.0,1.4,1.4,-3.5,-4.4,-5.5,-6.8,-7.6,-7.7
2017-06-23,0.4,0.9,-0.9,-0.8,-0.8,-1.6,-3.2,-4.2,-5.6,-6.5,-6.8
2017-06-26,-0.2,0.6,-0.7,0.7,0.7,-1.2,-3.3,-4.4,-5.7,-6.8,-7.1
2017-06-27,1.3,1.8,-0.0,-1.6,-1.6,0.9,-1.4,-2.3,-3.6,-4.8,-5.4
2017-06-28,-1.5,0.3,-1.9,1.9,1.9,-0.6,-2.7,-3.7,-4.9,-6.1,-6.8

2017-06-15: $ flows: buying on weakness: among stocks that were down thr, these had the largest net inflows of money: $v $amzn¡­ |rt AT_USER $amgn talk abt muscle memory. long term level of contention |rt AT_USER
2017-06-16: should we be interested in regeneron pharmaceuticals in 2017?  $regn $biib $amgn $sny|$amgn weekly. 20 ma acted as resistance. |amgen: a fairly valued biotech dividend growth play $amgn |rt AT_USER 3 
2017-06-17: abbvie $abbv ltm ebitda multiple trading below majority of peers: $bmy $lly $mrk $pfe $amgn  |{new video} biotech analysis + trade ideas: $ibb $xbi $celg $regn $agn $amgn $nbi --&gt;  |$amgn max pain 
2017-06-18: #amgen, dow, merck among 2017 green chemistry award winners. read more:  $amgn|$amgn oi for maturity 06/23/2017. 162.50 highest put. 172.50 highest call.  |amgen inc. $amgn price target raised to $184
2017-06-19: $amgn looking good with a bull flag on daily, touch of the 10 ema. looking for 174, 179 as next tps. with $ibb looking solid - it shud go|rt AT_USER i have no idea if this will happen but the  $clvs s
2017-06-20: follow #nasdaq 100 traders &amp; track their tweets under one watchlist $amgn $qcom  |like the recap title. the swing biotech list is huge money for members. $clvs $rdus $ptla $ions $amgn |$amgn will 
2017-06-21: rt AT_USER $amgn...what is left of a good spread...added the 175's today they ran down a bit :(  but pl doesn't show the stuff sol¡­|$amgn...what is left of a good spread...added the 175's today they 
2017-06-22: rt AT_USER $vdrm $frzt $chro $icnb $cnbx $owcp $usrm $aapl $nflx $fb $goog $znga $aezs $srpt $amgn $glbs $vrx $ocul $kerx $tsla $¡­|$amgn high open interest range is 162.50 to 172.50 for option expira
2017-06-23: rt AT_USER concerns about the senate healthcare bill - fireworks before the 4th of july  AT_USER $aet $hca $p¡­|rt AT_USER s&amp;p sees mild weekly gain, nasdaq outperforms as biotech shines $regn $ce
2017-06-24: $amgn high open interest range is 145.00 to 180.00 for option expiration 06/30/2017.  |rt AT_USER lr nice report out on large cap bio $ibb $celg $regn $amgn further 10% multiple expansion still likely
2017-06-25: $amgn oi for maturity 06/30/2017. 145.00 highest put. 180.00 highest call.  |rt AT_USER AT_USER AT_USER buyouts change everything $xbi $ibb $labu now where are they?!? cmon $gild $pfe $biib $amgn $mrk
2017-06-26: rt AT_USER $vdrm #fdanews #fda #news $amgn $alny $jnj $srpt $ptct $nvax $adxs $pbyi $mrk $clvs $mnkd $frzt $icnb $chro $eled |post-peak (jul 20, 2015 ) performance (not dividend adjusted). AT_USER #zz
2017-06-27: quality stocks are struggling, but these 50 show promise, goldman says  $amzn $pcln $mar $fb $amgn $aapl $tjx $nke|third time's a charm for $admp  #fda $chrs $amgn $itek $psdv $cara $rigl #neartermcat
2017-06-28: $fbio how sweet it is up ah $cost $amgn $zsan $tgtx $auph $oncs $tsla $kite $juno $clls $fb|$amgn i'm likely to find a reason to grab this one |rt AT_USER $vdrm #fdanews #fda #news $amgn $alny $jnj $s
Answer:
Fall